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Abstract
Background: Use of decellularized tissues has become popular in tissue engineering applications as the natural
extracellular matrix can provide necessary physical cues that help induce the restoration and development of
functional tissues. In relation to cochlear tissue engineering, the question of whether decellularized cochlear tissue
can act as a scaffold and support the incorporation of exogenous cells has not been addressed. Investigators have
explored the composition of the cochlear extracellular matrix and developed multiple strategies for decellularizing
a variety of different tissues; however, no one has investigated whether decellularized cochlear tissue can support
implantation of exogenous cells.
Methods: As a proof-of-concept study, human Wharton’s jelly cells were perfused into decellularized cochleae
isolated from C57BL/6 mice to determine if human Wharton’s jelly cells could implant into decellularized cochlear
tissue. Decellularization was verified through scanning electron microscopy. Cocheae were stained with DAPI and
immunostained with Myosin VIIa to identify cells. Perfused cochleae were imaged using confocal microscopy.
Results: Features of the organ of Corti were clearly identified in the native cochleae when imaged with scanning
electron microscopy and confocal microscopy. Acellular structures were identified in decellularized cochleae;
however, no cellular structures or lipid membranes were present within the decellularized cochleae when imaged
via scanning electron microscopy. Confocal microscopy revealed positive identification and adherence of cells in
decellularized cochleae after perfusion with human Wharton’s jelly cells. Some cells positively expressed Myosin
VIIa after perfusion.
Conclusions: Human Wharton’s jelly cells are capable of successfully implanting into decellularized cochlear
extracellular matrix. The identification of Myosin VIIa expression in human Wharton’s jelly cells after implantation
into the decellularized cochlear extracellular matrix suggest that components of the cochlear extracellular matrix
may be involved in differentiation.
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Background
Mammals are born with a limited number of functional
hair cells (HCs). These cells owe their name to stereo-
cilia that contain ion channels important for signal
transduction in the cochlea and therefore for hearing
sensation. Unfortunately, mammalian HCs unlike avian
HCs do not regenerate after damage [1]. Current HC
regeneration research endeavors rely on manipulating
gene expression in the sensory epithelium to induce HC
development [2–5], differentiating stem cells outside of
the body for implantation [6, 7], or using induction
methods to differentiate pluripotent stem cells into
cochlear organoids [8, 9]. However, while there has been
an emphasis on the stem cell differentiation and intra-
cellular gene manipulation [10, 11], could the cochlear
extracellular matrix (ECM) play a role in the function of
mechanosensory hair cells? Providing structural support
for organs and tissues, cell adhesion, differentiation, pro-
liferation, survival, polarity and migration of cells, pro-
teins, and structures of the ECM seem as vital as soluble
or genetic signals in governing cell differentiation and
tissue formation. The characterization of the cochlear
ECM has been well documented [12–14], and several
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investigators have documented the vital role of the ECM
in HC development [15–17]. Natural ECM has been
shown to provide valuable inductive signals to guide cell
phenotype and tissue regeneration [18]. However, no
one has investigated whether cochlear ECM could be
beneficial for sensory epithelium regeneration. Thus,
there is an opportunity to investigate the potential of
using the cochlear ECM as a scaffold to support cell
growth and potential development of sensory epithelium
engineering applications. Most of the studies on the im-
pact of cochlear ECM on cell behavior are limited to
two-dimensional surfaces or pseudo-three-dimensional
culture platforms. In order to create an artificial, but
nature-oriented three-dimensional microenvironment,
multiple factors need to be addressed such as compos-
ition, mechanics, porosity, and size. The concept of
using decellularized tissue as a scaffold for the develop-
ment of artificial organs has been used in clinical appli-
cations for nearly a decade [19], but the use of
decellularized cochleae has never been used as a
scaffold.
The cochlea is one of the smallest but most complex
organs of the human body. A huge diversity of cells
types and a highly impressive architecture makes regen-
eration even more complicated. It seems obvious that
approaches to regenerate this organ should be guided by
scaffolds that not only offer the chemical, but also the
physical cues of the ECM including the shape. Santi et
al. [20] have developed a method for decellularizing
cochleae (DCs) and creating scaffolds, which is valuable
for establishing feasibility. However, the impact of
these scaffolds on cells has not been investigated thus
far. The advantage of using a DC over a synthetic
scaffold is that the cochlea provides the exact physical
structure and shape of the extracellular environment
in which sensory epithelium develops, whereas other
scaffolds must be molded, tuned, or grown to mimic
the inside of the cochlea.
The current proof-of-concept study is the first to in-
vestigate whether DC cochlea can act as a tissue scaffold
and support growth of stem cells. Human Wharton’s
jelly cells (hWJCs), multipotent mesenchymal-like stem
cells isolated from the umbilical cord, were selected for
delivery into DCs, because they have shown the ability
in previous studies to differentiate toward a HC pheno-
type when HATH1 (human homolog of ATOH1) was
overexpressed [21–23]. Expression of HATH1 is re-
quired for HC commitment [11, 24]. It was hypothe-
sized that the cochlear ECM may provide physical
cues that support attachment of hWJCs. The purpose
of the current study was to verify that (1) mouse
cochleae could successfully be decellularized and (2)
determine whether cochlear ECM could support
growth of stem cells.
Methods
Procurement and decellularization of cochleae
Ten C57BL/6 female mice (approximately 6 weeks old)
were euthanized according to approved Institutional
Animal Care and Use Committee (IACUC) protocol
(ACUP #2014–2234) at University of Kansas Medical
Center (KUMC). One mouse was set aside, and fixed via
systemic perfusion with 4% paraformaldehyde (VWR,
Radnor, PA, USA) in PBS for 1 hour. The mouse was
decapitated, and both auditory complexes (cochlea and
vestibular organs) were removed via blunt dissection.
Cochleae were suspended in PBS, and used as native
controls (NC). All other mice were decapitated, and the
bulla was removed. The auditory complex of each ear
was isolated via blunt dissection for a total of 18 audi-
tory complexes. The stapes was removed from the oval
window and the round window membrane was punc-
tured on each cochlea. Each auditory complex (cochlea
and vestibular organs) was placed in a separate scintilla-
tion vial and perfused with 100 μL 2% penicillin-
streptomycin in Hank’s buffered saline solution (HBSS)
(Life Technologies, Grand Island, NY, USA) with a 28.5
gauge Ultra-Fine insulin needle and 3 mL syringe (BD
Biosciences, San Jose, CA, USA) over a duration of 2 -
minutes. An additional 400 μL of antibiotic solution was
added to each scintillation vial, and auditory complexes
were gently agitated for 24 hours on a rotator at 10 rpm.
All subsequent perfusions were performed with fresh
28.5 gauge Ultra-Fine insulin needles and 3 mL syringes
(BD Biosciences) and afterward samples were gently
agitated on a rotator at 10 rpm for 24 hours, unless
otherwise noted.
The following day, auditory complexes were washed with
phosphate-buffered saline (PBS) three times. Auditory
complexes were carefully perfused with 100 μL of decellu-
larization buffer consisting of 1% SDS in deionized (DI)
water (Life Technologies) with fresh changes and perfu-
sions for 3 days. Following decellularization, auditory com-
plexes were washed for 30 min in PBS three times each.
Afterward, auditory complexes were perfused with 100 μL
of decalcification buffer consisting of 10% EDTA in DI
water with daily changes and perfusions for 3 days. Follow-
ing decalcification, auditory complexes were washed for
30 min in PBS three times. Afterward, auditory complexes
were transferred to six-well plates (BD Biosciences) and
separated into two groups: (1) control (decellularized coch-
leae with no cells) or (2) hWJC-DC (decellularized coch-
leae perfused with hWJCs). Auditory complexes were
soaked in a 10% antibiotic-antimycotic solution (Life Tech-
nologies) in PBS overnight in a 4 °C refrigerator.
Procurement and expansion of hWJCs
hWJCs were isolated from Wharton’s jelly of human
umbilical cords according to the protocols approved by
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the University of Kansas Human Subjects Committee
(KU-Lawrence IRB approval #15402) and Stormont-Vail
(SMV) Hospital (SMV IRB approval conferred by IRB
Chair, Jo-Ann S. Harris, MD). Nursing staff obtained in-
formed consent from patients before collection of the
umbilical cords. Three umbilical cords (n = 3) were ob-
tained from Stormont-Vail (Topeka, KS, USA). All cords
were from males that were born at full term and deliv-
ered under normal delivery conditions.
hWJCs were isolated and cultured according to previ-
ous published protocols [23]. hWJCs were cultured in
hWJC medium consisting of 1% penicillin-streptomycin
(Life Technologies), 10% fetal bovine serum (FBS) mes-
enchymal stem cell qualified (MSCq) (Life Technolo-
gies), and fibroblast basal medium (Lonza Group Ltd.,
Basel, Switzerland), and expanded to passage 5 for all
experiments.
Transfection
A subset of hWJCs were divided into two groups: (1)
unmodified hWJCs (no transfection) and (2) HATH1-
transfected hWJCs. hWJCs were transfected with 0.5 μg
HATH1 plasmid DNA according to previous published
protocols using a 4D-Nucleofector (Lonza Group Ltd.)
at a ratio of 100,000 cells per transfection [23]. Cells
were cultured for 7 days in a two-dimensional six-well
plate (BD Biosciences). Cells were imaged at 1 and 7 days
following transfection and seeding.
Decellularized cochlea perfusion
A total of 6 DCs were reserved as untreated controls.
The remaining 12 DCs were presoaked with 37 °C hWJC
medium 1 hour prior to perfusion. DCs were perfused
with 100 μL containing 100,000 unmodified hWJCs
using a 28.5 gauge Ultra-Fine insulin needle and 3 mL
syringe (BD Biosciences) in six-well plates (BD Biosci-
ences). Perfusions were administered over a 2-minute
duration for each cochlea. After cells were perfused into
DCs, 2 mL of prewarmed hWJC medium was added to
each well. Perfused cochleae were placed in a 37 °C cell
culture incubator. Cochleae were cultured for 7 days and
cell culture medium was replaced with 2.5 mL of fresh
hWJC medium every 2 days.
Tissue preparation
After 7 days of culture, cochleae were fixed overnight in
4% paraformaldehyde (VWR) in PBS at 4 °C. NCs, and
two control DCs that were not perfused with hWJCs,
were stained for 24 hours with 2% osmium tetroxide
(OT), because OT embeds between lipids, and produces
a strong electron backscatter signal when bombarded by
an electron beam. Afterward, OT-stained samples were
washed three times for 10 minutes in PBS. All samples
were gradually dehydrated with ethanol and cleared in
xylene, before being embedded with paraffin. Samples
were sectioned to a thickness of 10 μm using a micro-
tome (Leica, Buffalo Grove, IL, USA) and mounted on
SuperFrost glass slides (Thermo Fisher Scientific,
Waltham, MA, USA).
Scanning electron microscopy
OT-stained samples were deparaffinized in two washes
of xylene for 3 minutes each. Afterward, OT samples
were critical-point dried in 100% ethanol using an Auto-
samdri 815B (Tousimis, Rockville, MD, USA). Samples
were sputter-coated with 5 nm of copper using a Q150T
Turbo-Pumped Sputter Coater (Quorum Technologies,
Lewes, UK). Samples were imaged using a Versa 3D
Dual Beam electron microscope (FEI, Hillsboro, OR,
USA) at a voltage of 30 kV. The Everhart-Thornley de-
tector (ETD) was used to detect secondary electrons
while the circular backscatter (CBS) detector was used
to detect backscatter electrons. The OT stain was used
to detect lipid content (or lack thereof ) in biological
samples to identify cellular membranes. The aforemen-
tioned scanning electron microscopy (SEM) technique
enables visual identification and differentiation between
cellular and acellular structures within the sample, which
allows for confirmation that cochleae have been decellu-
larized. In addition, cells that have been perfused into
decellularized tissues can be detected, based on the
backscatter signal of the lipids from cellular structures
or microvesicles.
Immunohistochemistry
After paraffin embedding, samples were deparaffinized
in two washes of xylene, and gently rehydrated over
30 minutes with a series of decreasing ethanol solutions
in PBS. Samples were incubated in 3% hydrogen perox-
ide in PBS for 10 minutes at room temperature to block
endogenous peroxidase activity. Afterward, samples
were washed twice for 5 minutes each with PBS.
Samples were incubated twice with 0.2% Tween 20
(Sigma-Aldrich, St. Louis, MO, USA) in PBS for
10 minutes each. Afterward, samples were washed
with PBS twice. Samples were blocked for 1 hour
with primary blocking solution [6% bovine serum
albumin (BSA) (Fisher Scientific, Pittsburgh, PA, USA),
10% normal donkey serum (NDS) (Life Technologies) in
PBS]. Afterward, samples were incubated overnight at 4 °C
with a dilution of 1:100 primary antibody (Rabbit Anti-
Human MYOSIN VIIA (MYO7A) (Cat No: NBP1 84266;
Novus Biologicals, Littleton, CO, USA). The following day,
samples were washed with PBS three times for 5 minutes
each. Samples were incubated overnight with a secondary
antibody conjugated to a fluorophore (Donkey Anti-Rabbit
Qdot 525 (Cat. No. Q22074; Life Technologies)) at a dilu-
tion of 2:100 secondary antibody to secondary blocking
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solution. The following day, samples were washed three
times with PBS for 5 minutes each, and counterstained
with DAPI (Life Technologies) according to the manufac-
turer’s instructions. Afterward, glass coverslips were
mounted over samples with Histomount Mounting Solu-
tion (Life Technologies) according to the manufacturer’s
instructions.
Microscopy
Whole-mount samples were imaged via an Olympus
IX81 inverted epifluorescent microscope (Olympus
America, Center Valley, PA, USA) at a magnification
of × 20. A montage of neighboring fields of view was
stitched together in the acquisition software, Slide-
book (Intelligent Imaging Innovations [3i], Denver,
CO, USA), to create an image of the entire cochlear
and vestibular section. Afterward, specific regions of
interest were imaged using an Olympus IX81/31 spin-
ning disk confocal microscope (Olympus America) at
a magnification of × 40.
Results
Native cochleae revealed anatomical and cellular
structures intact
Native cochleae (NC) were imaged via scanning electron
microscopy (SEM) using the ETD. Anatomical features
of the organ of Corti were clearly discernable (Fig. 1).
The tectorial membrane, Reissner’s membrane, outer
hair cells, cochlear nerve, spiral ligament, and basilar
membrane were clearly identified in NC samples. In
DCs, fibrils of the ECM were visible, and the anatomical
landmarks such as the basilar membrane, spiral limbus,
and spiral ligament were intact (Fig. 2).
No cellular features were detected in decellularized
cochleae
No lipid or other cellular structures were detected; how-
ever, key features of the cochlear duct were still intact
and identifiable, such as the basilar membrane, spiral
limbus, and osseous spiral lamina, which suggest that
while the decellularization process removed cells, the
physical structure of the cochlea remained intact. NCs
that were not decellularized displayed a strong backscat-
ter signal, which was consistent with cellular features
identified in the organ of Corti, whereas little to no
backscatter signal was detected in samples that were
decellularized (Fig. 3).
Attachment of hWJCs in decellularized cochleae
The ECM from DCs supported attachment of hWJCs.
Multiple regions and surfaces of the DCs were covered
with hWJCs after 7 days of culture with the identifica-
tion of 200 cells or more in whole-mount cochlear sec-
tions (Fig. 4). Cells were most commonly detected along
the spiral ligament and osseous labyrinth where the stria
vascularis existed prior to decellularization. Immuno-
cytochemical staining revealed the presence of MYO7A
in some of the hWJCs following 7 days of culture (Fig. 5).
To verify MYO7A expression in hWJCs, a culture of
unmodified and HATH1-transfected hWJCs were cul-
tured in two-dimensional six-well plates for 7 days
(Fig. 6). Only hWJCs transfected with HATH1 displayed
MYO7A expression.
Fig. 1 Scanning electron microscopy images of native mouse
cochlea. The Everhart-Thornley detector (ETD) was used for imaging.
In panel a, all the major components housed in the cochlear duct
are labeled and present. Panel b, represents the inset in panel a,
which magnifies the organ of Corti. Panel c represents the inset in
panel b, which is a magnification of the outer hair cells. Panel a scale
bar = 100 μm. Panel b scale bar = 40 μm. Panel c scale bar = 10 μm
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Discussion
Utilizing the decellularization protocol developed by
Santi et al. [20], decellularization of C57BL/6 cochleae
were confirmed by different methods, which demon-
strated that the protocol used was sufficient for removal
of cells. Furthermore, a classic SEM technique was ap-
plied in an innovative way to discern cellular and
acellular structures within the decellularized cochlea at a
high resolution. For the first time DCs were shown to
function as a scaffold for attachment of hWJCs. The
only cues influencing cell behavior were from the ECM,
as the shape and structure of the cochlea were pre-
served. However, the presence of some cell debris (e.g.,
proteins) cannot be ruled out as still being present.
Fig. 2 Scanning electron microscopy images of decellularized mouse cochlea. The Everhart-Thornley detector (ETD) was used for imaging.
In panel a, the medial portions of the cochlea are shown, and the extracellular structures, which include the spiral limbus and osseous
spiral lamina are intact; however, no cellular structures are identifiable. Panel b shows the lateral portion of the cochlear duct, in which
the basilar membrane and spiral ligament are identified, but the organ of Corti is not present. The extracellular fibers are clearly visible in
both panels. Panel a scale bar = 50 μm. Panel b scale bar = 100 μm
Fig. 3 Comparison of lipid content via scanning electron microscopy. No lipid content was detected in cochlear sections that were decellularized
(DCs). No cells were present on the basilar membrane of DCs. Native cochlea (NC) sections displayed positive backscatter signal for lipid content.
The Everhart-Thornley detector (ETD) is a standard secondary electron detector used in scanning electron microscopy, while the circular backscatter
(CBS) is a backscatter detector. When tissues are stained with osmium tetroxide (OT), the OT embeds within lipids, and gives off a strong backscatter
signal. Native cochlea scale bar = 50 μm. Decelled cochlea scale bar = 20 μm
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The attachment and survival hWJCs into the cochlear
ECM suggests that the DC could serve as a tissue scaf-
fold, and potentially be used as a substrate to engineer
sensory epithelium. The current study is a first step that
could lead to the creation of a model that could be used
to analyze how the cochlear ECM supports development
and maintenance of sensory epithelium in the cochlea.
There is a growing interest in investigating how the ECM
of cochlea supports the maintenance and function sensory
epithelium. Goodyear and Richardson [25] and Hayashi et
al. [26] have provided a detailed characterization of the
composition of the tectorial membrane from different
mammalian species, and have noted how differences in
acellular composition and structure of the tectorial mem-
brane affects the function of inner HCs and OCs in the
organ of Corti. Furthermore, Liu et al. [27] have investi-
gated the structure of the basilar membrane, and provided
some of the most detailed structural images to date on
how the basilar membrane interacts with support cells
and changes in width and stiffness from the base to apical
end. The potential now exists to examine how the coch-
lear ECM affects stem cell differentiation independent of
bioactive signaling.
Biochemical analysis of the extracellular components
in the DC where cells attached could provide critical
information about the key molecules involved in HC
differentiation, and whether cells have actually incorpo-
rated into the matrix or have merely attached. Neuronal
path-finding as well as migration and differentiation of
cells during embryonic development is supported by cell
adhesion molecules [28–30].
While the current study was a proof-of-concept
endeavor, there are many aspects of the cochlear ECM left
to explore and several aspects left to address, which will
enhance the use of DCs as tissue constructs. The
visualization of decellularized tissue through SEM and the
corroboration of decellularization through assessment of
Fig. 4 Whole-mount cochlea comparison of implanted human
Wharton’s jelly cells. Human Wharton’s jelly cells (hWJCs) were
perfused through the oval window of the cochlea. Confocal images
of whole-mount cochleae displayed clear identification of 200 cells
or more per cochlea slice. In the cochlea slice presented, 230 cells
were identified. Cells attached to the basilar membrane (BM), spiral
ligament (SLig), stria vasularis (SV), and spiral limbus (SLim) as
indicated by white arrows. Cell nuclei were stained with DAPI
(blue). Scale bar = 100 μm
Fig. 5 Myosin VIIA identification in hWJCs perfused through
decellularized cochleae. Human Wharton’s jelly cells (hWJCs) were
stained with DAPI (blue) to identify cell nuclei, while the motor protein,
Myosin VIIA (MYO7A) was identified via immunohistochemical staining
(red). After 7 days of culture, a handful of adherent hWJCs displayed
positive identification of MYO7A, which is a marker of early hair cell
commitment. Cochlear matrix is shown in green as a result of
autofluorescence. Scale bar = 100 μm
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DNA quantity within the decellularized tissue would pro-
vide a compelling examination of how thoroughly tissues
have (or have not) been decellularized for use in tissue
engineering applications. Refinement of decellularization
techniques would be prudent for ensuring no debris or
cellular epitopes from residual intracellular proteins are
present in DCs. It may be possible to improve cell integra-
tion into DCs by varying the seeding density of hWJCs. In
addition, changing the rate of perfusion or direction of
perfusion could improve cell seeding in DCs. Interestingly,
the seeding of alternative stem cell types may yield differ-
ent rates of integration and differentiation potential.
Injecting cells through the habenula perforata may allow
access to the basilar membrane [31, 32]. Creating serial
sections of the DC could additionally yield interesting
opportunities to infuse cells from different geometries,
and allow for manipulation of several variables in the
extracellular environment. Furthermore, the current study
is limited by the duration at which perfused cells were
assessed. Examining cochleae perfused with hWJCs, or
other cell types for greater than 7 days, such as 12 to
15 days, would be advantageous for assessing cell prolifer-
ation [using the bromodeoxyuridine (BrdU) assay], and
whether any cells are undergoing apoptosis [by terminal
deoxynucleotidyl transferase UTP nick-end labeling
(TUNEL) assay]. An additional limitation of the study is
the assessment of only MYO7A. Quantification of
HATH1 expression and identification of additional bio-
markers, such as Prestin, miR-96, miR-182, and miR183
would provide greater confidence in the ability of hWJCs
to commit to a hair cell phenotype [33, 34]. It remains to
be seen if other cell phenotypes found in the sensory epi-
thelium such as support cells and spiral ganglion cells
could be identified by assessing expression of Nectin3 and
SNAP25, respectively [35, 36]. Follow-up studies which
expand the assessment of biomarkers and duration of cells
grown in the cochlea could provide valuable information
for leveraging the decellularized cochlea as a scaffold for
engineering sensory epithelium, and greatly contribute to
the trend of using decellularized tissues for regenerative
medicine applications.
Conclusions
The current study was a successful first step in develop-
ing a tissue construct, which has remarkable techno-
logical significance. Culturing cells in the ECM of DCs
provides a means to assess the role that the extracellular
environment may play in the development and mainten-
ance of sensory epithelium when bioactive signals are
absent from host cells. Future studies elucidating how
the cochlear ECM supports the development, function,
and maintenance of sensory epithelium could provide
Fig. 6 hWJCs transfected with HATH1 and MYO7A expression. a Non-transfected hWJCs (day 1). b hWJCs transfected with HATH1 (day 1).
c Non-transfected hWJCs (day 7). d hWJCs transfected with HATH1 (day 7). (Blue = DAPI, green = Myosin VIIA) Scale bar = 50 microns
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new insights to sensorineural pathology, which could
lead to the development of new strategies for regenerat-
ing sensory epithelium including HCs, support cells, and
spiral ganglion neurons.
Highlights
 Cochleae were isolated from mice and
decellularized.
 Decellularization was verified and compared against
native controls using an innovative electron
microscopy technique.
 Major acellular structural features of decellularized
cochlea remained intact.
 HumanWharton’s jelly cells were successfully
seeded into decellularized cochleae.
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